Showing results (281-290 of 501) with videos related to

Sort By:
Pageof 51
Head & Neck|September 17, 2009
HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North AmericansJessica H Maxwell, Bhavna Kumar, Felix Y Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab VedotinCarissa E Chu, Martin Sjöström, Emily A Egusa, et al.
Cancer|June 29, 2019
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national databaseAmandeep R Mahal, Santino Butler, Idalid Franco, et al.
European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.
Elife|December 28, 2022
Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectorsJoseph M Replogle, Jessica L Bonnar, Angela N Pogson, et al.
Cell Reports|March 29, 2018
Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma ProliferationHarish N Vasudevan, Steve E Braunstein, Joanna J Phillips, et al.
European Urology|June 2, 2018
The Diverse Genomic Landscape of Clinically Low-risk Prostate CancerMatthew R Cooperberg, Nicholas Erho, June M Chan, et al.
Translational Oncology|November 13, 2014
A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancerKyle C Cuneo, Thomas L Chenevert, Edgar Ben-Josef, et al.
European Urology Oncology|December 12, 2024
Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate CancerMark C Markowski, Yi Ren, Meghan Tierney, et al.
Frontiers in Endocrinology|March 3, 2020
Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer CellsAnna R Michmerhuizen, Benjamin Chandler, Eric Olsen, et al.
Pageof 51